FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1964809738> ?p ?o ?g. }

• W1964809738 endingPage "2712" @default.
• W1964809738 startingPage "2705" @default.
• W1964809738 abstract "Only a minority of myelodysplastic syndrome (MDS) patients respond to hypomethylating agents (HMAs), but strong predictors of response are unknown. We sequenced 40 recurrently mutated myeloid malignancy genes in tumor DNA from 213 MDS patients collected before treatment with azacitidine (AZA) or decitabine (DEC). Mutations were examined for association with response and overall survival. The overall response rate of 47% was not different between agents. Clonal TET2 mutations predicted response (odds ratio [OR] 1.99, P = .036) when subclones unlikely to be detected by Sanger sequencing (allele fraction <10%) were treated as wild-type (WT). Response rates were highest in the subset of TET2 mutant patients without clonal ASXL1 mutations (OR 3.65, P = .009). Mutations of TP53 (hazard ratio [HR] 2.01, P = .002) and PTPN11 (HR 3.26, P = .006) were associated with shorter overall survival but not drug response. Murine-competitive bone marrow transplantation followed by treatment with AZA demonstrated that Tet2-null cells have an engraftment advantage over Tet2-WT cells. AZA significantly decreased this advantage for Tet2-null cells (P = .002) but not Tet2-WT cells (P = .212). Overall, Tet2 loss appears to sensitize cells to treatment with AZA in vivo, and TET2 mutations can identify patients more likely to respond to HMAs." @default.
• W1964809738 created "2016-06-24" @default.
• W1964809738 creator A5001392592 @default.
• W1964809738 creator A5001854862 @default.
• W1964809738 creator A5002930435 @default.
• W1964809738 creator A5003947352 @default.
• W1964809738 creator A5012348736 @default.
• W1964809738 creator A5049115435 @default.
• W1964809738 creator A5051382926 @default.
• W1964809738 creator A5053453125 @default.
• W1964809738 creator A5061026876 @default.
• W1964809738 creator A5062180760 @default.
• W1964809738 creator A5070668676 @default.
• W1964809738 creator A5071023119 @default.
• W1964809738 creator A5072026752 @default.
• W1964809738 creator A5090366405 @default.
• W1964809738 creator A5090435894 @default.
• W1964809738 creator A5090527595 @default.
• W1964809738 creator A5091223719 @default.
• W1964809738 date "2014-10-23" @default.
• W1964809738 modified "2023-10-15" @default.
• W1964809738 title "TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients" @default.
• W1964809738 cites W1972169553 @default.
• W1964809738 cites W1976573435 @default.
• W1964809738 cites W1978358623 @default.
• W1964809738 cites W1985704394 @default.
• W1964809738 cites W1992320498 @default.
• W1964809738 cites W1993236149 @default.
• W1964809738 cites W2005458309 @default.
• W1964809738 cites W2015776863 @default.
• W1964809738 cites W2017394727 @default.
• W1964809738 cites W2021327643 @default.
• W1964809738 cites W2026134786 @default.
• W1964809738 cites W2034676880 @default.
• W1964809738 cites W2041596445 @default.
• W1964809738 cites W2041745252 @default.
• W1964809738 cites W2062135903 @default.
• W1964809738 cites W2070152906 @default.
• W1964809738 cites W2073889874 @default.
• W1964809738 cites W2081895311 @default.
• W1964809738 cites W2114492363 @default.
• W1964809738 cites W2114867684 @default.
• W1964809738 cites W2116205277 @default.
• W1964809738 cites W2117333061 @default.
• W1964809738 cites W2118771330 @default.
• W1964809738 cites W2123355582 @default.
• W1964809738 cites W2125062167 @default.
• W1964809738 cites W2133838758 @default.
• W1964809738 cites W2138601221 @default.
• W1964809738 cites W2157783208 @default.
• W1964809738 cites W2166506757 @default.
• W1964809738 cites W2168133698 @default.
• W1964809738 cites W2169007954 @default.
• W1964809738 cites W4247053599 @default.
• W1964809738 doi "https://doi.org/10.1182/blood-2014-06-582809" @default.
• W1964809738 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4208285" @default.
• W1964809738 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25224413" @default.
• W1964809738 hasPublicationYear "2014" @default.
• W1964809738 type Work @default.
• W1964809738 sameAs 1964809738 @default.
• W1964809738 citedByCount "467" @default.
• W1964809738 countsByYear W19648097382013 @default.
• W1964809738 countsByYear W19648097382014 @default.
• W1964809738 countsByYear W19648097382015 @default.
• W1964809738 countsByYear W19648097382016 @default.
• W1964809738 countsByYear W19648097382017 @default.
• W1964809738 countsByYear W19648097382018 @default.
• W1964809738 countsByYear W19648097382019 @default.
• W1964809738 countsByYear W19648097382020 @default.
• W1964809738 countsByYear W19648097382021 @default.
• W1964809738 countsByYear W19648097382022 @default.
• W1964809738 countsByYear W19648097382023 @default.
• W1964809738 crossrefType "journal-article" @default.
• W1964809738 hasAuthorship W1964809738A5001392592 @default.
• W1964809738 hasAuthorship W1964809738A5001854862 @default.
• W1964809738 hasAuthorship W1964809738A5002930435 @default.
• W1964809738 hasAuthorship W1964809738A5003947352 @default.
• W1964809738 hasAuthorship W1964809738A5012348736 @default.
• W1964809738 hasAuthorship W1964809738A5049115435 @default.
• W1964809738 hasAuthorship W1964809738A5051382926 @default.
• W1964809738 hasAuthorship W1964809738A5053453125 @default.
• W1964809738 hasAuthorship W1964809738A5061026876 @default.
• W1964809738 hasAuthorship W1964809738A5062180760 @default.
• W1964809738 hasAuthorship W1964809738A5070668676 @default.
• W1964809738 hasAuthorship W1964809738A5071023119 @default.
• W1964809738 hasAuthorship W1964809738A5072026752 @default.
• W1964809738 hasAuthorship W1964809738A5090366405 @default.
• W1964809738 hasAuthorship W1964809738A5090435894 @default.
• W1964809738 hasAuthorship W1964809738A5090527595 @default.
• W1964809738 hasAuthorship W1964809738A5091223719 @default.
• W1964809738 hasBestOaLocation W19648097381 @default.
• W1964809738 hasConcept C104317684 @default.
• W1964809738 hasConcept C126322002 @default.
• W1964809738 hasConcept C143998085 @default.
• W1964809738 hasConcept C150194340 @default.
• W1964809738 hasConcept C190727270 @default.
• W1964809738 hasConcept C203014093 @default.
• W1964809738 hasConcept C207103383 @default.

• next